Q3 2020 13F Holders as of 30 Sep 2020
-
Type / Class
-
Equity / Common Stock, $0.01 par value
-
Shares outstanding
-
66,587,586
-
Number of holders
-
14
-
Total 13F shares, excl. options
-
874,509
-
Shares change
-
+16,714
-
Total reported value, excl. options
-
$2,789,000
-
Value change
-
+$51,390
-
Number of buys
-
5
-
Number of sells
-
-2
-
Price
-
$3.19
Significant Holders of Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) as of Q3 2020
15 filings reported holding ARMP - Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value as of Q3 2020.
Armata Pharmaceuticals, Inc. - Common Stock, $0.01 par value (ARMP) has 14 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 874,509 shares
of 66,587,586 outstanding shares and own 1.31% of the company stock.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (633,944 shares), RENAISSANCE TECHNOLOGIES LLC (93,698 shares), BlackRock Inc. (40,952 shares), EDGEWOOD MANAGEMENT LLC (40,000 shares), STIFEL FINANCIAL CORP (19,729 shares), VANGUARD GROUP INC (15,150 shares), SeaCrest Wealth Management, LLC (12,655 shares), WEDBUSH SECURITIES INC (10,103 shares), BANK OF MONTREAL /CAN/ (2,444 shares), and Tower Research Capital LLC (TRC) (2,270 shares).
This table shows the top 14 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.